A clinical trial to study the effects of two drugs, Levobupivacaine and Ropivacaine in tonsillar pillar block in patients undergoing tonsillectomy.
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/07/069703
- Lead Sponsor
- Dr. Vishnu Sadanandan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
American society of anesthesiologist patient status (asa-ps) 1 and 2
Exclusion Criteria
1. Patients with signs of acute pharyngeal infections.
2. Patients with fever.
3. Patients with peritonsillar abscess.
4. Patients with bleeding disorders.
5. Patients with drug allergies.
6. Patients who refuse to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To compare the post-operative analgesic efficacy of Levobupivacaine and Ropivacaine using NRS (numerical rating scale) and analgesic requirement over the first 24 hours.Timepoint: 15 months
- Secondary Outcome Measures
Name Time Method Recording adverse effects, including bleeding, nausea, vomiting & otalgia if any, post operatively.Timepoint: 15 months